myron J. levin, MD

Professor
University of Colorado Anschutz Medical Campus

Disclosure: Curevo (Individual(s) Involved: Self): Advisor or Review Panel member; GlaxoSmithKline (Individual(s) Involved: Self): Advisor or Review Panel member, Grant/Research Support; Merck Research Laboratories (Individual(s) Involved: Self): Advisor or Review Panel member; Merck ResearchLaboratories (Individual(s) Involved: Self): Advisor or Review Panel member

Presentation(s):

• 5 - How Does Frailty Impact the Efficacy, Reactogenicity, Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine? A Secondary Analysis of the ZOE-50 and ZOE-70 Studies

  Oral Abstract